1 / 18

CASE 21

CASE 21. Michelle Legaspi.

isanne
Télécharger la présentation

CASE 21

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CASE 21 Michelle Legaspi

  2. 65 y/o male retired teacher sought consult because of occasional chest heaviness non-radiating occuring during a moderate physical exertion (e.g. climbing up the stairs, or carrying a heavy object), or after an emotional outburst. He noticed that this was often relieved by rest or relaxation with duration 5-10 minutes. He also claims to have a positive family history of heart disease

  3. Angina Pectoris • Pain in the chest • Characteristic: heaviness • Relieved by rest • Male: 50-60 years old • Usually due to atherosclerotic heart disease • Classic Angina or “angina of effort” • Impaired oxygen delivery as a result of abnormalities of the coronary arteries

  4. Laboratory Examinations • vital signs • patient history • physical exam • ECG • ST depression during treadmill test

  5. Plan of Management • Pharmacologic • Beta blockers • Nitrates • Calcium channels blockers • Non-Pharmacologic a. Stop smoking b. Decrease alcohol consumption c. Stress management d. Decrease fat and cholesterol in diet e. Lose weight f.  Decease salt intake

  6. Pharmacokinetics • Nitrates • First past effect (liver-nitrate reductase) • Bioavailability: low 10-20% • Route: • Sublingual: avoids the 1st past effect • Oral: longer duration of action • Buccal • Spray • IV • Transdermal • Ointment • Metabolites • 2 dinitroglycerin: significant vasodilator efficacy; most therapeutic effect of oral route • 2 mononitro • Excretion: kidney in the form of glucuronide derivative

  7. Pharmocodynamics • Dilates all the smooth muscles, biliary systems, ureters and bronchioles • Relaxing action is most active in the blood vessels • Anti-angina effect is due to a reduction on peripheral arterial resistance and thus decrease in after load • Dilate veins: reduce venous return • Results in decrease in left ventricular volume makes the heart move efficiently • Decrease in both the preload and afterload as a result of respective dilation of venous capacitance and arteriolar resistance vessel

  8. Side effects • Throbbing headache • Flushing of the face • Dizziness especially in the beginning of treatment • Postural hypotension due to the pooling of blood in the dependent portions of the body

  9. Contraindication • Renal ischemia • Acute myocardial infarction • Patients receiving other anti-hypertensive agents

  10. Beta Adrenergic Blocking Drugs • Beneficial • Hemodynamic effect • Decrease heart rate, blood pressure, contractility • Decrease myocardial oxygen requirements at rest and during exercise • Increase in diastolic perfusion time • Reduce heart rate and blood pressure • Reduce myocardial oxygen consumption

  11. Side effects • Increase end-diastolic volume • Increase in ejection time • Increase myocardial oxygen associated with increased diastolic volume • Can be balanced by the use of nitrates

  12. Contraindication • Congestive heart failure • decrease in cardiac output; heart compensate by increasing heart rate • Asthma • block beta 1 and beta 2 receptor • Complete heart block • heart rate is slow • DM • inhibit insulin and stimulate glucagon

  13. Calcium channel blockers • Pharmacokinetics • Inhibits calcium transport, excitation-contraction and cardiac work are depressed. • Peripheral vasodilation which further reduces cardiac work load • Pharmacodynamics • Relaxes and reduces the tone of all smooth muscles • Relaxing action is marked on vascular smooth muscle • Arterioles are much more affected than veins • Lower blood pressure and reduce afterload without appreciable effect on the preload

  14. Side effects • Nausea and vomiting • Dizziness • Flushing • Tachycardia: due to hypotension

  15. Contraindication • Cardiogenic shock • Recent myocardial infarction • Heart failure • Atrio-ventricular block

  16. Combination therapy • Nitrate and Beta blockers • beta blockers block reflex tachycardia • Calcium channel blockers and beta blockers • exertional angina that is not controlled • Calcium channel blocker and nitrates • severe vasopastic or exertional angina w/ CHF and sick sinus syndrome • Calcium channel blocker, Beta blockers and Nitrate • exertional angia not controlled by administration of two types of anti-anginal agent

  17. Nitrates • Short acting • Nitroglycerin, sublingual • Isosorbide dinitrate, sublingual • Amyl nitrite, inhalant • Long acting • Nitroglycerin, oral sustained-action • Nitroglycerin, 2% ointment, transdermal • Nitroglycerin, slow-release, buccal • Nitroglycerin, slow-release patch, transdermal • Isosorbide dinitrate, sublingual • Isosorbide dinitrate, oral • Isosorbide dinitrate, chewable oral • Isosobide monoitrate oral

  18. Beta Adrenergic Blocking Drugs • Popranolol • absorbed well in the GIT, • t1/2 = 3-5 hours • Nadolol • Calcium Channel Blockers • Nifedipine • Verafamil • Diltiazem

More Related